HealthcareAI Research5 min reading time

Novo Nordisk and AWS bring agentic AI into drug discovery

AI News (TechForge)
Read full post
Novo Nordisk is partnering with AWS to integrate AI agents into drug discovery, establishing a co-innovation hub in London to accelerate research from target identification to clinical dosing. The collaboration leverages AWS cloud and AI tools, including generative AI, to enhance workflows and reduce documentation time significantly.

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources
Healthcare5 min read

​Digital Finance Needs A New Kind Of Identity For AI-Driven Economies

Forbes

How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules

Open AI News